HEALTH PROFESSIONAL · SOURCE READING

Clinical trials

Source: Thyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 9, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Papillary and Follicular Thyroid Cancer / Treatment Options for Papillary and Follicular Thyroid Cancer / Recurrent papillary and follicular thyroid cancer

Patients with recurrent papillary or follicular thyroid cancer should consider enrolling in clinical trials evaluating new treatment approaches to this disease. Oral inhibitors targeting specific single nucleotide variants are under clinical evaluation, as are new immunotherapy approaches.[27-29][Level of evidence B4]

Source links and citations

27
29
Level of evidence B4

Publication references

Read the original reference and check its publication notices.

PubMed 18596272 · Original source
PubMed 29455653 · Original source

Preserved source evidence · Not medical advice